These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9471334)

  • 1. [Sudden cardiac death in the aged].
    Dúbrava M
    Bratisl Lek Listy; 1997; 98(7-8):400-6. PubMed ID: 9471334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors and prevention of sudden cardiac death in patients with ventricular tachycardia after myocardial infarct].
    Kaliská G; Szentiványi M; Kmec P; Alberty R
    Vnitr Lek; 1999 Jan; 45(1):22-9. PubMed ID: 10422522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?
    Dagres N; Hindricks G
    Eur Heart J; 2013 Jul; 34(26):1964-71. PubMed ID: 23644180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden cardiac death risk factors in patients with heart failure treated with carvedilol.
    Nessler J; Nessler B; Kitliński M; Libionka A; Kubinyi A; Konduracka E; Piwowarska W
    Kardiol Pol; 2007 Dec; 65(12):1417-22; discussion 1423-4. PubMed ID: 18181053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional heart failure medications and sudden cardiac death prevention: a review.
    Al Chekakie MO
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):412-26. PubMed ID: 23766358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of antiarrhythmic drug therapy for the prevention of sudden cardiac death.
    Kamath GS; Mittal S
    Prog Cardiovasc Dis; 2008; 50(6):439-48. PubMed ID: 18474286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and predictors of sudden cardiac death in patients with reduced left ventricular ejection fraction after myocardial infarction in an era of revascularisation.
    Fan X; Hua W; Xu Y; Ding L; Niu H; Chen K; Xu B; Zhang S
    Heart; 2014 Aug; 100(16):1242-9. PubMed ID: 24895352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden cardiac death in postmyocardial-infarction patients.
    Fahed J; Floyd KC; Tighe DA
    Panminerva Med; 2015 Jun; 57(2):71-86. PubMed ID: 25669163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ventricular arrhythmias and sudden cardiac death in acute myocardial infarct in the era of thrombolytics].
    Jurkovicová O; Spitzerová H; Cagán S
    Bratisl Lek Listy; 1997; 98(7-8):379-89. PubMed ID: 9471331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-arrhythmia agents in the prevention of sudden cardiac death after myocardial infarct].
    Cagán S; Jurkovicová O
    Bratisl Lek Listy; 1997; 98(7-8):413-22. PubMed ID: 9471336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiarrhythmic agents in the prevention of sudden cardiac death].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):117-20. PubMed ID: 10365592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical management and prevention of sudden cardiac death.
    Yousuf O; Chrispin J; Tomaselli GF; Berger RD
    Circ Res; 2015 Jun; 116(12):2020-40. PubMed ID: 26044254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists?
    Stevenson WG; Ridker PM
    JAMA; 1996 Aug; 276(6):481-5. PubMed ID: 8691557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.
    Abildstrom SZ; Ottesen MM; Rask-Madsen C; Andersen PK; Rosthøj S; Torp-Pedersen C; Køber L
    Int J Cardiol; 2005 Sep; 104(2):184-9. PubMed ID: 16168812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory ECG-based T-wave alternans monitoring for risk assessment and guiding medical therapy: mechanisms and clinical applications.
    Verrier RL; Ikeda T
    Prog Cardiovasc Dis; 2013; 56(2):172-85. PubMed ID: 24215749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
    Peck KY; Lim YZ; Hopper I; Krum H
    Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.